InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Edwards Martin, Director. Director active across 3 companies, notably Verona Pharma plc. In total, 10 reports have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €111k. Activity tracked since 4 May 2021. The latest transaction was disclosed on 20 November 2023 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
2,376 sharesCommon StockSEC:0001415889-24-021823:0
33,736 shares@ US$1.83787.1% of flowOrdinary SharesSEC:0001104659-23-120809:0
Ideal exit: 16 Aug 2024 (T+270)
2,376 shares@ US$20.54100.0% of flowCommon StockSEC:0001209191-23-055428:0
Ideal exit: 9 Aug 2024 (T+270)
6,116 sharesClass A common stockSEC:0000899243-23-019533:0
133 shares@ US$93.6144.5% of flowClass A common stockSEC:0001209191-23-035769:0
359 shares@ US$34.7680.4% of flowClass A common stockSEC:0001209191-22-035381:0
59 shares@ US$27.32100.0% of flowClass A common stockSEC:0001209191-22-001623
59 shares@ US$27.329.8% of flowClass A common stockSEC:0001209191-22-001623:0
12,024 shares@ US$0.8397100.0% of flowOrdinary SharesSEC:0001104659-21-061805:0
12,024 sharesOrdinary SharesSEC:0001104659-21-061805
10 of 10 declarations
About Edwards Martin
Martin Edwards is a Director at Verona Pharma plc and Reata Pharmaceuticals Inc. He participates in the governance of these companies, bringing his expertise in biopharmaceuticals and drug development. His role is essential for guiding strategic decisions and supporting the growth of the companies.
